Evidence map›Paper›PMID 42549301›Full record

ArticleJournal of inflammation research2026

Predicting Anastomotic Leak After Neoadjuvant Chemoimmunotherapy and Esophagectomy: A Dynamic Inflammatory and Nutritional Biomarker Model.

Zhenyuan Yang, Yizhou Huang, Maohui Chen, Bingqiang Cai, Hongmu Li, Taidui Zeng, Shuliang Zhang, Chun Chen, Bin Zheng

Abstract read
In one paragraph

Article in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhenyuan Yang *Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
Yizhou Huang *Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
Maohui Chen *Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
Bingqiang CaiDepartment of Thoracic Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, People's Republic of China.
Hongmu LiDepartment of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
Taidui ZengDepartment of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
Shuliang ZhangDepartment of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
Chun ChenDepartment of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
Bin ZhengDepartment of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.ORCID 0000-0001-8429-5384

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To determine the incidence of anastomotic leak (AL) following esophagectomy after neoadjuvant immunochemotherapy (NICT) for esophageal squamous cell carcinoma (ESCC) and to develop a novel prediction model integrating dynamic inflammatory and nutritional biomarkers. Patients and Methods: This two-center, retrospective study enrolled 550 patients (350 in training cohort, 200 in external validation cohort) with locally advanced ESCC who underwent NICT followed by esophagectomy. For each inflammatory and nutritional index, we calculated the change (Δ) from before NICT to before surgery. Multivariable logistic regression was used to identify independent predictors and construct the prediction model for AL. Model performance was assessed by area under the curve (AUC), calibration, and decision curve analysis. Results: The incidence of AL was 10.57% (training) and 11.50% (validation). Most leaks were cervical (93.33%), of Grade II/III severity (78.33%), and nearly half led to anastomotic stenosis (46.67%). The final prediction model incorporated ΔNPR_cat, ΔPAR_cat, ΔHALP_cat and two clinical variables (BMI < 18.5 kg/m Conclusion: AL remains a significant complication after NICT and esophagectomy. We established and validated a practical prediction model that dynamically integrates biomarker trajectories and clinical factors. This tool may help identify high-risk patients preoperatively and thereby support the implementation of tailored perioperative strategies, such as intensified monitoring, proactive nutritional support, or selective anastomotic protection measures.

Indexed as

anastomotic leakageesophageal carcinomaesophagectomyneoadjuvant immunochemotherapyprediction model

Identifiers

PMID42549301
PMCPMC13431432

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.